For Immediate Release
April 16, 2018

Rochester Hills, MI – A relentless four-year effort in market and product development of the iSperm^TM has resulted in significant industry recognition for both Aidmics Biotechnology Co., Ltd. And Breeder’s Choice, Inc. The iSperm is a portable animal semen evaluation system interfacing with an Apple iPad Mini 4. Notable events for the iSperm in 2018 include FDA registration in the United States, approval from Ministry of Agriculture, Forestry & Fisheries (MAFF) in Japan, and successful completion of an academic study by the Theriogenology Laboratory of Ohio State University comparing equine semen results of iSperm with recognized standard laboratory equipment.

With increased industry recognition, iSperm will be represented at important industry trade events around the world, aiming to create impact in the animal reproduction industry. During the upcoming 2018 Therio Conference in Milwaukee, WI, researchers from Ohio State University will present a paper describing their findings. iSperm has been adopted by independent vets, academic institutes, and clinics mostly for field use in the United States, the United Kingdom, and Australia. In Taiwan, the success rate of insemination for farms that are equipped with iSperm is higher than the average, according to statistics.

In the equine market, iSperm features portability, intuitive sampling methods, and validated accuracy for both mare and stud owners, who can be reassured the semen doses are of high quality prior to shipment or insemination. Based on image detection and processing technologies, iSperm can evaluate concentration, motility, and progressive motility for equine and other agricultural species. These readings can further be analyzed to optimize the reproduction efficiency in agriculture. Once infertility problems are identified with iSperm, veterinarians can conduct corresponding treatment earlier and more effectively